Evgen Pharma plc
Evgen Pharma plc (EVG.L) Company Profile & Overview
Explore Evgen Pharma plc’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.
Evgen Pharma plc (EVG.L) Company Profile & Overview
Evgen Pharma plc, a clinical stage drug development company, focuses on the development of sulforaphane-based medicines for the treatment of cancer and inflammatory diseases. It develops its products using Sulforadex, a sulforaphane stabilization technology. The company's lead product is SFX-01, that is in Phase II clinical trials for the treatment of metastatic breast cancer; and in Phase Ib/IIa clinical trials for the treatment of glioblastoma, as well as in preclinical stage for the treatment of haematological malignancies and analogues. It also provides out-licensing of its technology services. Evgen Pharma plc was incorporated in 2014 and is headquartered in Nether Alderley, the United Kingdom.